Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D₃ oral rinsing was associated with reduced detection by saliva-based SARS-CoV-2 RAT while RT-PCR results remained largely preserved.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Single-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this prospective, paired-sample, single-blind clinical trial, 25 adults with laboratory-confirmed SARS-CoV-2 infection provided saliva immediately before and after a standardized one-minute Vitamin D₃ oral rinse (50 paired specimens).

Source: Abstract.

Eligible participants were symptomatic outpatients with laboratory-confirmed SARS-CoV-2 infection diagnosed during their clinical visit.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D3 oral rinsing reduces salivary SARS-CoV-2 antigen detectability: a clinical trial with public health implications

Study design awaiting verification · Frontiers in Oral Health · 2026

Original publication title

Vitamin D3 oral rinsing reduces salivary SARS-CoV-2 antigen detectability: a clinical trial with public health implications

Sarah M. Nizar Feteih; Emily L. G. Heaphy; Amjad Aljagthmi; Abdullah Abumdaini; Daniyah Bayumi; Ghadeer Albishi; Ashraf Dada

© 2026 Feteih, Heaphy, Aljagthmi, Abumdaini, Bayumi, Albishi and Dada.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D₃ oral rinsing was associated with reduced detection by saliva-based SARS-CoV-2 RAT while RT-PCR results remained largely preserved. These findings suggest a previously under-recognized pre-analytical variable capable of altering saliva-based antigen detection.

Clinical Trial Registration: https://clinicaltrials.gov/study/NCT07068282, Identifier, NCT07068282.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To determine whether a Vitamin D3 oral rinse alters the performance of saliva-based SARS-CoV-2 rapid antigen testing (RAT) and assess its potential implications for infectious disease screening and public health surveillance.

Source: Objectives

Abstract: What methods does the paper describe?

In this prospective, paired-sample, single-blind clinical trial, 25 adults with laboratory-confirmed SARS-CoV-2 infection provided saliva immediately before and after a standardized one-minute Vitamin D₃ oral rinse (50 paired specimens). Samples were analyzed in parallel by saliva RAT and rapid RT-PCR under blinded conditions.

Source: Methods

Abstract: Results

The oral rinse converted 68% (17/25) of paired specimens from RAT-positive to RAT-negative, reducing antigen positivity from 54.2% to 32.0% (p = 0.0016). In contrast, RT-PCR positivity remained largely preserved (96.0% vs. 88.0%), with no significant change in mean Ct values (28.1 ± 5.9 vs. 29.4 ± 5.1; p = 0.1785). Strong concordance between paired RT-PCR samples (ρ = 0.814, p < 0.0001) indicated persistent viral RNA despite reduced antigen detection.

Source: Results

Abstract: Conclusions

Vitamin D₃ oral rinsing was associated with reduced detection by saliva-based SARS-CoV-2 RAT while RT-PCR results remained largely preserved. These findings suggest a previously under-recognized pre-analytical variable capable of altering saliva-based antigen detection.

Clinical Trial Registration: https://clinicaltrials.gov/study/NCT07068282, Identifier, NCT07068282.

Source: Conclusions Source: Conclusions
Authors’ abstract

Objectives

To determine whether a Vitamin D3 oral rinse alters the performance of saliva-based SARS-CoV-2 rapid antigen testing (RAT) and assess its potential implications for infectious disease screening and public health surveillance.

Methods

In this prospective, paired-sample, single-blind clinical trial, 25 adults with laboratory-confirmed SARS-CoV-2 infection provided saliva immediately before and after a standardized one-minute Vitamin D₃ oral rinse (50 paired specimens). Samples were analyzed in parallel by saliva RAT and rapid RT-PCR under blinded conditions.

Results

The oral rinse converted 68% (17/25) of paired specimens from RAT-positive to RAT-negative, reducing antigen positivity from 54.2% to 32.0% (p = 0.0016). In contrast, RT-PCR positivity remained largely preserved (96.0% vs. 88.0%), with no significant change in mean Ct values (28.1 ± 5.9 vs. 29.4 ± 5.1; p = 0.1785). Strong concordance between paired RT-PCR samples (ρ = 0.814, p < 0.0001) indicated persistent viral RNA despite reduced antigen detection.

Conclusions

Vitamin D₃ oral rinsing was associated with reduced detection by saliva-based SARS-CoV-2 RAT while RT-PCR results remained largely preserved. These findings suggest a previously under-recognized pre-analytical variable capable of altering saliva-based antigen detection.

Clinical Trial Registration: https://clinicaltrials.gov/study/NCT07068282, Identifier, NCT07068282.

Publication and source details

Original title: Vitamin D3 oral rinsing reduces salivary SARS-CoV-2 antigen detectability: a clinical trial with public health implications

Sarah M. Nizar Feteih; Emily L. G. Heaphy; Amjad Aljagthmi; Abdullah Abumdaini; Daniyah Bayumi; Ghadeer Albishi; Ashraf Dada

Frontiers in Oral Health · 2026

* Correspondence: Sarah M. Nizar Feteih sfeteih@kfshrc.edu.sa Ashraf Dada a.dada@kfshrc.edu.sa© 2026 Feteih, Heaphy, Aljagthmi, Abumdaini, Bayumi, Albishi and Dada.2026Feteih, Heaphy, Aljagthmi, Abumdaini, Bayumi, Albishi and Dadahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T11:48:01+00:00

DOI: 10.3389/froh.2026.1943222 · PMC13574574